Microbiome Connect : Skin - USA 2021

Translating the latest skin microbiome research from the clinic to the consumer

Find out more
COURTYARD BY MARRIOTT, BOSTON DOWNTOWN BOUTIQUE HOTEL
17-18 November, 2021

“Skin microbiome today is exploding with companies all over the world. Now we’re at a point where the awareness is so great that there’s almost like a tidal wave of interest in microbiome!”

Mike Conti, Solabia

Why Attend

Love the skin you’re in? How about the bugs on it?

Over the six years we’ve run Microbiome Connect: Skin, the field has changed drastically. In a short period, the field has gone from fringe to mainstream, from quantifying the size of bacterial populations to understanding their function. As the field continues to commercialize, it is time to ask how this research can benefit consumers. How can the skin microbiome be leveraged as a source of biomarkers, as a therapeutic modality, as an understandable term to consumers?

Join us in Boston for a two-day face-to-face event, attended in the past by the likes of P&G, Jackson Laboratory, and the FDA. Unravel the function of the skin microbiome and apply the latest findings to your future products. See you in November!

Here’s a sneak peek of some key takeaways:

  • Establish skin microbiome friendly hygiene products to meet consumer demands related to the pandemic, with Codex Beauty and Sanex
  • Find out how to maintain regulatory standards and avoid litigation around claims with Q&A and presentations from FDA and NAD
  • Discover how to use functional prebiotics to feed beneficial bacteria and increase product development price efficiency and convenience with Cybele Microbiome and Colgate Palmolive
  • Tap into personalized skincare with pore specific Cutibacterium acnes data and analytics from Tami Lieberman and Dermala
  • Leverage phage, LBP and autologous bactherapeutics to target skin disease with AOBiome, Azitra, Matrisys, BiomX and more

"This event is a unique gathering of individuals from academia and industry who are collaborating to advance microbiome science. Kisaco has gone out of their way to include speakers and perspectives not found elsewhere. I look forward to attending again" KC Communications Group

Advisory Board

Author:

Jay Tiesman

Research Fellow - Genomics Group Leader
Proctor & Gamble

Dr. Jay Tiesman is a Principal Scientist in the Global Biotechnology Division of The Procter & Gamble Company in Cincinnati, Ohio, USA. He is the Genomics Group Leader and a Corporate Technology Entrepreneur – charged with helping to identify novel biotechnology innovations worldwide to address key needs for P&G. Since joining P&G in 1993, he has been actively involved in developing genomics capabilities within the Company. He has been particularly interested in the use of genomics to gain insight into epithelial cell biology.

Before joining P&G, he completed postdoctoral training in the laboratory of Dr. Charlie Hart at ZymoGenetics, Inc. in Seattle, Washington. At ZymoGenetics, he pursued research in the field of growth factor signal transduction associated with wound healing and tissue remodeling. He obtained his Ph.D. in Pathology from the University of Nebraska Medical Center in Omaha, Nebraska. In Omaha, he worked in the Laboratory of Dr. Angie Rizzino at the Eppley Cancer Institute, delineating the roles and impact of growth factors on embryonic development. Before joining Dr. Rizzino, he obtained Bachelor degrees in Philosophy and Biology at Creighton University in Omaha.

Dr. Tiesman was an early adopter of microarray technology, having worked in the field since 1997. He is an acknowledged microarray expert and has published over 35 articles, two of which have earned “Publication of the Year” honors. He also speaks extensively at international meetings on the topic of microarray experimental design and is listed on over 85 presentations. He collaborates extensively with scientists in academia and the biotechnology industry and is a member of several academic/governmental/industrial organizations, including the Association of Biomedical Resource Facilities Microarray Research Group (ABRF-MARG), the Association of Molecular Pathology (AMP), and the Society for Investigative Dermatology (SID); as well as the Scientific Advisory Board of NuGEN Technologies, Inc.

Jay Tiesman

Research Fellow - Genomics Group Leader
Proctor & Gamble

Dr. Jay Tiesman is a Principal Scientist in the Global Biotechnology Division of The Procter & Gamble Company in Cincinnati, Ohio, USA. He is the Genomics Group Leader and a Corporate Technology Entrepreneur – charged with helping to identify novel biotechnology innovations worldwide to address key needs for P&G. Since joining P&G in 1993, he has been actively involved in developing genomics capabilities within the Company. He has been particularly interested in the use of genomics to gain insight into epithelial cell biology.

Before joining P&G, he completed postdoctoral training in the laboratory of Dr. Charlie Hart at ZymoGenetics, Inc. in Seattle, Washington. At ZymoGenetics, he pursued research in the field of growth factor signal transduction associated with wound healing and tissue remodeling. He obtained his Ph.D. in Pathology from the University of Nebraska Medical Center in Omaha, Nebraska. In Omaha, he worked in the Laboratory of Dr. Angie Rizzino at the Eppley Cancer Institute, delineating the roles and impact of growth factors on embryonic development. Before joining Dr. Rizzino, he obtained Bachelor degrees in Philosophy and Biology at Creighton University in Omaha.

Dr. Tiesman was an early adopter of microarray technology, having worked in the field since 1997. He is an acknowledged microarray expert and has published over 35 articles, two of which have earned “Publication of the Year” honors. He also speaks extensively at international meetings on the topic of microarray experimental design and is listed on over 85 presentations. He collaborates extensively with scientists in academia and the biotechnology industry and is a member of several academic/governmental/industrial organizations, including the Association of Biomedical Resource Facilities Microarray Research Group (ABRF-MARG), the Association of Molecular Pathology (AMP), and the Society for Investigative Dermatology (SID); as well as the Scientific Advisory Board of NuGEN Technologies, Inc.

Author:

Sarah De Szalay

R&D Director
Stealth Health Startup

Sarah De Szalay

R&D Director
Stealth Health Startup

Author:

Larry Weis

CSO & Founder
Symbiome

 

Larry Weis

CSO & Founder
Symbiome

 

Author:

Trevor Steyn

CEO & Founder
Esse Organic Skincare

Trevor Steyn is the CEO and founder of Esse Skincare. As an organic chemist his research has taken a broader approach to optimising skin health in the long term. Esse launched its first live probiotic product in February 2015 and has subsequently pioneered several new technologies in modulating the skin microbiome.  

 

Trevor Steyn

CEO & Founder
Esse Organic Skincare

Trevor Steyn is the CEO and founder of Esse Skincare. As an organic chemist his research has taken a broader approach to optimising skin health in the long term. Esse launched its first live probiotic product in February 2015 and has subsequently pioneered several new technologies in modulating the skin microbiome.  

 

Author:

Ingmar Claes, PhD

Chief Scientific Officer
YUN Probiotherapy

Ingmar studied bioscience engineering at the University of Leuven, graduated in 2007 and obtained a PhD in cell and gene technology in 2011. He has an expertise in the field of probiotics, its molecular mechanisms and the topical application of these beneficial bacteria to restore the human microbiome. As bioengineer and microbiologist, he feels that it is important to translate this scientific research into daily products from which people at home and the community can benefit.

In the context of YUN, he is closely working together with the Department of Bioscience Engineering of the University of Antwerp, the Lab of Applied Microbiology and Biotechnology of prof. Sarah Lebeer, the Lab of Pharmaceutical Technology and Biopharmacy of prof. Filip Kiekens, prof. dr. Julien Lambert (dermatology) and dr. Gilbert Donders (gynaecology, the University Hospital of Antwerp).

He has experience with leadership in multiple R&D projects and he held a managing role in YUN’s R&D projects of the Flemish Institute for the Promotion of Scientific and Technological Research in Industry (VLAIO). YUN’s current range of probiotic products and therapies were developed under his supervision.

 

Ingmar Claes, PhD

Chief Scientific Officer
YUN Probiotherapy

Ingmar studied bioscience engineering at the University of Leuven, graduated in 2007 and obtained a PhD in cell and gene technology in 2011. He has an expertise in the field of probiotics, its molecular mechanisms and the topical application of these beneficial bacteria to restore the human microbiome. As bioengineer and microbiologist, he feels that it is important to translate this scientific research into daily products from which people at home and the community can benefit.

In the context of YUN, he is closely working together with the Department of Bioscience Engineering of the University of Antwerp, the Lab of Applied Microbiology and Biotechnology of prof. Sarah Lebeer, the Lab of Pharmaceutical Technology and Biopharmacy of prof. Filip Kiekens, prof. dr. Julien Lambert (dermatology) and dr. Gilbert Donders (gynaecology, the University Hospital of Antwerp).

He has experience with leadership in multiple R&D projects and he held a managing role in YUN’s R&D projects of the Flemish Institute for the Promotion of Scientific and Technological Research in Industry (VLAIO). YUN’s current range of probiotic products and therapies were developed under his supervision.

 

Author:

Dr Chris Callewaert

Post-doctoral researcher
Centre for Microbial Ecology & Technology, Ghent University

Chris received his PhD from Ghent University in Belgium. He is now a postdoctoral research fellow in the Knight lab at the University of California, San Diego. He investigates body odor and the characteristics of the bacteria living in the armpits, skin, clothes, washing machines and homes. He is the first to undertake bacterial transplants to solve underarm body odour.

Dr Chris Callewaert

Post-doctoral researcher
Centre for Microbial Ecology & Technology, Ghent University

Chris received his PhD from Ghent University in Belgium. He is now a postdoctoral research fellow in the Knight lab at the University of California, San Diego. He investigates body odor and the characteristics of the bacteria living in the armpits, skin, clothes, washing machines and homes. He is the first to undertake bacterial transplants to solve underarm body odour.

Author:

Audrey Gueniche Ph.D

HEAD OF INTERNATIONAL SCIENTIFIC VALORISATION LUXURY DIVISION
L'Oréal

Audrey GUENICHE obtained her Pharmacist degree and her PhD degree in skin biology more than 23 years ago. She is an expert on immunology and microbiology. Her main expertise is on skin topical treatment and food supplement for skin and hair health, especially using probiotics, natural extract and bacterial extracts. She is currently a senior clinical expert in LOREAL RESEARCH. She has a complete experience from the actives through vitro evaluations/ preclinical studies to clinical trials. Her passion is to always reinvent evaluation and find new fields of area in term of actives to promote. 

She has published over 110 papers in peer-reviewed journals, 5 chapters in books, 2 specials issues in journal where she was the invited editor. She presented in over 80 international congresses and additionally she was personally invited to give more than 35 keynote lectures.

Audrey Gueniche Ph.D

HEAD OF INTERNATIONAL SCIENTIFIC VALORISATION LUXURY DIVISION
L'Oréal

Audrey GUENICHE obtained her Pharmacist degree and her PhD degree in skin biology more than 23 years ago. She is an expert on immunology and microbiology. Her main expertise is on skin topical treatment and food supplement for skin and hair health, especially using probiotics, natural extract and bacterial extracts. She is currently a senior clinical expert in LOREAL RESEARCH. She has a complete experience from the actives through vitro evaluations/ preclinical studies to clinical trials. Her passion is to always reinvent evaluation and find new fields of area in term of actives to promote. 

She has published over 110 papers in peer-reviewed journals, 5 chapters in books, 2 specials issues in journal where she was the invited editor. She presented in over 80 international congresses and additionally she was personally invited to give more than 35 keynote lectures.

Author:

Erwan Peltier

Senior Medical Manager Dermatology
Bayer Consumer Care AG

Erwan Peltier

Senior Medical Manager Dermatology
Bayer Consumer Care AG

Author:

Cath O’Neill

Chief Scientific Officer
SkinBio Therapeutics

Cath O’Neill

Chief Scientific Officer
SkinBio Therapeutics

Who will be there

Meet Industry Leading Experts including:

  • Independent Beauty Brands and Biotech Companies;
  • Academic Researchers and Dermatologists;
  • Multinational Beauty & Personal Care Brands and Multinational Pharmaceutical Companies;
  • Cosmetic Formulators, Strain Manufacturers, Ingredients Suppliers, Packaging Manufacturers and Sequencing companies; 
  • Regulatory Experts and Consumer Trend Analysts; and
  • Retailers and Distributors

Past attendees include: 

HIGHLIGHTS FROM PREVIOUS MICROBIOME CONNECT: SKIN EVENTS

Skin Microbiome Congress Boston

Speakers

 

Tami Lieberman

Assistant Professor
Massachusetts Institute of Technology (MIT)

Tami Lieberman joined the MIT faculty in January 2018. She leads a computational and experimental research group focused on uncovering the principles governing colonization, niche range, and personalization in the human microbiome.

Tami Lieberman

Assistant Professor
Massachusetts Institute of Technology (MIT)

Tami Lieberman

Assistant Professor
Massachusetts Institute of Technology (MIT)

Tami Lieberman joined the MIT faculty in January 2018. She leads a computational and experimental research group focused on uncovering the principles governing colonization, niche range, and personalization in the human microbiome.

Tami trained in molecular biology and mathematics at Northwestern University, where she conducted research in the laboratory of Jon Widom and was funded by a Barry M. Goldwater Scholarship. She then earned a PhD in Systems Biology from Harvard University, where she conducted research in Roy Kishony’s laboratory. During her graduate research, Tami developed new genomic approaches for understanding how bacteria evolve during infections of individual people. As a postdoc in Eric Alm’s lab at MIT, she further developed and applied these genomic approaches to understand the microbes that colonize us during health. Tami has also made contributions to our understanding of antibiotic resistance, including the co-invention of a new platform for visualizing evolution in real time. Her work has been covered in the popular press, including online coverage from The Atlantic, The Wall Street Journal, National Geographic, The Boston Globe, and ArsTechnia.

 

Huiying Li

Assistant Professor
UCLA

Huiying Li

Assistant Professor
UCLA

Huiying Li

Assistant Professor
UCLA
 

Larry Weiss

Chief Science and Product Officer
Symbiome

Larry Weiss

Chief Science and Product Officer
Symbiome

Larry Weiss

Chief Science and Product Officer
Symbiome
 

Greg Hillebrand

Scientist
Amway R&D

Greg Hillebrand

Scientist
Amway R&D

Greg Hillebrand

Scientist
Amway R&D
 

Barbara Paldus

CEO
CODEX Beauty

Barbara Paldus

CEO
CODEX Beauty

Barbara Paldus

CEO
CODEX Beauty
 

Nicole Scott

Founder & CEO
Cybele Microbiome

Nicole Scott

Founder & CEO
Cybele Microbiome

Nicole Scott

Founder & CEO
Cybele Microbiome
 

Anahid Ugurlayan

Deputy Director
National Advertising Review Board

Anahid Ugurlayan

Deputy Director
National Advertising Review Board

Anahid Ugurlayan

Deputy Director
National Advertising Review Board
 

Matthew Steele

Regulatory Information Specialist
FDA

Matthew Steele

Regulatory Information Specialist
FDA

Matthew Steele

Regulatory Information Specialist
FDA
 

Todd Krueger

President & CEO
AOBiome

Todd Krueger

President & CEO
AOBiome

Todd Krueger

President & CEO
AOBiome
 

Philippe Calais

CEO
Matrisys Bioscience

Philippe Calais

CEO
Matrisys Bioscience

Philippe Calais

CEO
Matrisys Bioscience
 

Travis Whitfill

Co-Founder and Chief Scientific Officer
Azitra

Travis Whitfill is an Associate Research Scientist in the Department of Pediatrics. His background began in molecular biology and biochemistry, after receiving scientific training at the MD Anderson Cancer Center and Duke University. He is the co-founder of several additional startup companies, including a Connecticut-based microbiome company, Azitra Inc. He brings strong background in entrepreneurship and business, and is also a partner in a venture capital fund, Bios Partners, bringing experience in public markets, drug development, and venture capital investments.

Travis Whitfill

Co-Founder and Chief Scientific Officer
Azitra

Travis Whitfill

Co-Founder and Chief Scientific Officer
Azitra

Travis Whitfill is an Associate Research Scientist in the Department of Pediatrics. His background began in molecular biology and biochemistry, after receiving scientific training at the MD Anderson Cancer Center and Duke University. He is the co-founder of several additional startup companies, including a Connecticut-based microbiome company, Azitra Inc. He brings strong background in entrepreneurship and business, and is also a partner in a venture capital fund, Bios Partners, bringing experience in public markets, drug development, and venture capital investments.

His research interests are in pediatric emergency medicine and health policy and to improve pediatric acute care across the United States. 

 

Teruaki Nakatsuji

Associate Project Scientist
USCD

Teruaki Nakatsuji

Associate Project Scientist
USCD

Teruaki Nakatsuji

Associate Project Scientist
USCD
 

Søren Kjærulff

Founder & Chief Executive Officer
LactoBio

Søren Kjærulff

Founder & Chief Executive Officer
LactoBio

Søren Kjærulff

Founder & Chief Executive Officer
LactoBio
 

Rachel Behm

CEO & Founder
Layers Probiotic Skincare

Rachel Behm

CEO & Founder
Layers Probiotic Skincare

Rachel Behm

CEO & Founder
Layers Probiotic Skincare
 

Assaf Oron

Chief Business Officer
Biomx

Assaf Oron

Chief Business Officer
Biomx

Assaf Oron

Chief Business Officer
Biomx
 

Steven Rosenfeld

CEO
Columbia SkinCare

Steven Rosenfeld

CEO
Columbia SkinCare

Steven Rosenfeld

CEO
Columbia SkinCare
 

Sarah De Szalay

R&D Director
Stealth Health Startup

Sarah De Szalay

R&D Director
Stealth Health Startup

Sarah De Szalay

R&D Director
Stealth Health Startup
 

Min Li

Technical Associate
Colgate Palmolive

Min Li

Technical Associate
Colgate Palmolive

Min Li

Technical Associate
Colgate Palmolive
 

Lada Rasochova

Founder & CEO
Dermala

Lada Rasochova

Founder & CEO
Dermala

Lada Rasochova

Founder & CEO
Dermala
 

Eric Clarke

Head of Sales
Labskin

Eric Clarke

Head of Sales
Labskin

Eric Clarke

Head of Sales
Labskin
 

Nicola Kingswell

Chief Scientist and Head of Laboratories
Labskin

Nicola Kingswell

Chief Scientist and Head of Laboratories
Labskin

Nicola Kingswell

Chief Scientist and Head of Laboratories
Labskin

Headline Partner

Platinum Event Partners

Gold Event Partner

Silver Event Partners

Bronze Partner

Event Partners

PARTNER WITH US

Based on your objectives, we can create bespoke packages designed specifically for you. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding, and Networking.

CONTACT US TO FIND OUT MORE

Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]

Download 2021 Agenda!

Love the skin you’re in? How about the bugs on it?

Join over 200+ key opinion leaders and 20+ expert speakers from the likes of MIT, UCLA and Amway Global Discovery. Microbiome Connect: Skin USA has dedicated content to translate the latest skin microbiome data and market analysis into beauty and personal care products. 

Here’s a sneak peek of some key takeaways:

  • Establish skin microbiome friendly hygiene products to meet consumer demands related to the pandemic, with Codex Beauty and Sanex
  • Find out how to maintain regulatory standards and avoid litigation around claims with Q&A and presentations from FDA and NAD
  • Discover how to use functional prebiotics to feed beneficial bacteria and increase product development price efficiency and convenience with Cybele Microbiome and Colgate Palmolive
  • Tap into personalized skincare with pore specific Cutibacterium acnes data and analytics from Tami Lieberman and Dermala
  • Leverage phage, LBP and autologous bactherapeutics to target skin disease with AOBiome, Azitra, Matrisys, BiomX and more

Download our Agenda

Conference Packages

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:

TICKET PRICE WILL INCREASE IN

Preparing registration...

Venue

COURTYARD BY MARRIOTT, BOSTON DOWNTOWN BOUTIQUE HOTEL, 275 TREMONT STREET, BOSTON, MA 02116

Not sure where you stay? check out this hotel map, which marks all of the local hotels and prices just for you.

 

Resources

Download Resource

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us